Published in Tubercle on June 01, 1979
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax (1998) 4.52
Short course chemotherapy for tuberculous lymphadenitis in children. BMJ (1990) 1.51
Trends in tuberculosis. Postgrad Med J (1984) 1.36
Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Thoracic Society Research Committee. Br Med J (Clin Res Ed) (1985) 0.85
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Audit of a tuberculosis contact tracing clinic. BMJ (1992) 2.80
Detecting and reducing hospital adverse events: outcomes of the Wimmera clinical risk management program. Med J Aust (2001) 2.61
What is the optimum duration of anticoagulation for the management of patients with idiopathic deep venous thrombosis and pulmonary embolism? J R Coll Physicians Edinb (2010) 2.36
Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle (1977) 2.35
Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83
Survey of pulmonary tuberculosis in south and west Wales (1976-8). Br Med J (Clin Res Ed) (1982) 1.78
Anticoagulants in venous thromboembolism. BMJ (1988) 1.77
Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax (2001) 1.67
Oxygen as a driving gas for nebulisers: safe or dangerous? Br Med J (Clin Res Ed) (1984) 1.60
Management of spontaneous pneumothorax-a Welsh survey. Postgrad Med J (2000) 1.53
Interaction between isoprenaline and aminophylline in asthma. Thorax (1977) 1.52
Pulmonary infection with mycobacterium xenopi: review of treatment and response. Thorax (1984) 1.50
Twice daily slow-release theophylline vs placebo for 'morning-dipping' in asthma. Br J Clin Pharmacol (1984) 1.48
Ketotifen in adult asthma. Br Med J (1980) 1.40
"Opportunist" mycobacterial infections. Thorax (2000) 1.39
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax (1981) 1.35
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax (1983) 1.32
How important is the sequence of administration of inhaled beclomethasone dipropionate and salbutamol in asthma. Br J Dis Chest (1981) 1.23
Monitoring effects of oral anticoagulants during treatment with heparin. Br Med J (Clin Res Ed) (1984) 1.18
Management of extra-pulmonary tuberculosis (excluding miliary and meningeal) in south and west Wales (1976-8). Br Med J (Clin Res Ed) (1982) 1.11
Humidifier fever in an operating theatre. Br Med J (1979) 1.07
Tuberculosis contact tracing: are the British Thoracic Society guidelines still appropriate? Thorax (1992) 1.07
Stopping smoking. Do nicotine chewing-gum and postal encouragement add to doctors' advice. Practitioner (1987) 1.05
A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis. Br J Dis Chest (1982) 1.04
Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax (2002) 1.03
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med (1993) 1.02
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clin Lab Haematol (1987) 1.00
Effect of a "stop smoking" booklet on smokers attending for chest radiography: a controlled study. Thorax (1986) 0.98
Infection with parvovirus during pregnancy. Br Med J (Clin Res Ed) (1985) 0.97
Guidelines to control heparin treatment. Br Med J (Clin Res Ed) (1986) 0.94
Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A. Gut (1992) 0.93
Refined tuberculosis contact tracing in a low incidence area. Respir Med (1998) 0.92
Costs and getting ethical approval deter doctors from participating in multicentre trials. BMJ (1996) 0.87
Retrospective survey of the management of miliary tuberculosis in South and West Wales, 1976-8. Thorax (1983) 0.87
Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis. Thorax (1997) 0.85
Audit of control of heparin treatment. Br Med J (Clin Res Ed) (1985) 0.85
Neutropenia with each standard antituberculosis drug in the same patient. Br Med J (1980) 0.84
Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma. Br J Clin Pharmacol (1986) 0.84
Letter: Ethambutol and the eye; zinc and copper. Lancet (1975) 0.83
Intrabronchial metastases from renal carcinoma with recurrent tumour expectoration. Thorax (1981) 0.82
Intermittent positive-pressure breathing. Br Med J (1978) 0.82
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med (2003) 0.81
Acute myeloid leukaemia presenting with pleural effusions. Clin Lab Haematol (1989) 0.81
Use of flutter VRP1 in the management of patients with steroid-dependent asthma. Respiration (1994) 0.81
Dielectric investigation of the temperature dependence of the nonexponentiality of the dynamics of polymer melts. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.81
A smoking cessation counsellor: should every hospital have one? J R Soc Promot Health (1998) 0.80
Ordering in Heisenberg spin glasses. Phys Rev Lett (2002) 0.80
Totally implantable venous access devices in adult patients with cystic fibrosis. Respir Med (1996) 0.80
Attitudes to smoking and smoking habits among hospital staff. Thorax (1993) 0.80
Indoramin--an alpha adrenoreceptor antagonist for airway obstruction. Br J Dis Chest (1977) 0.79
Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax (1984) 0.79
Determinants of free theophylline clearance in asthma. Br J Clin Pharmacol (1987) 0.78
Is indoramin useful in the treatment of bronchial asthma? Br J Dis Chest (1980) 0.78
Pulmonary strongyloidiasis and lung abscess. Chest (1981) 0.78
Nutrition in adults with cystic fibrosis. Clin Nutr (1998) 0.78
Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease. J Infect Dis (2000) 0.78
Active surveillance for tuberculosis in Wales: 1996-2003. Arch Dis Child (2006) 0.78
Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale. Thorax (1985) 0.77
Proton magnetic resonance studies of histidines in human, rhesus monkey, and bovine carbonic anhydrases. Biochim Biophys Acta (1977) 0.76
CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. Tissue Antigens (2001) 0.76
Antituberculosis drug levels after jejunoileal bypass. Br J Dis Chest (1982) 0.76
Toxicity of isoniazid and rifampicin combination. Thorax (1995) 0.75
Aggressive psychosis in AIDS patient on high-dose steroids. Lancet (1987) 0.75
Plasma theophylline concentrations. Br Med J (Clin Res Ed) (1985) 0.75
A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism. Afr Health Sci (2009) 0.75
Safety profile of bupropion for chronic obstructive pulmonary disease. Lancet (2001) 0.75
Late complication of plombage thoracoplasty. Thorax (1985) 0.75
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis (1995) 0.75
Clinical presentation and investigation of patients proceeding to isotope lung scanning for suspected pulmonary embolism. Postgrad Med J (1990) 0.75
Comparison of salmefamol and salbutamol in patients with chronic airways obstruction. Br J Clin Pharmacol (1976) 0.75
How to intervene against smoking. J R Coll Physicians Lond (2000) 0.75
Nicotine patches in general practice. BMJ (1993) 0.75
Inhaled steroids and dysphonia. Lancet (1984) 0.75
Ising ferromagnet in dimension five: link and spin overlaps. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.75
Studies in cutaneous immunofluorescence. I. The effect of storage time on direct immunofluorescence of skin biopsies from bullous disease and lupus erythematosus. J Cutan Pathol (1980) 0.75
Auger injuries in the Wimmera region 1987-95. Aust N Z J Surg (1996) 0.75
Peak-flow meter versus peak-flow gauge. Lancet (1974) 0.75
An assessment of prilocaine as a topical anaesthetic agent for fibreoptic bronchoscopy in comparison with lidocaine. Acta Anaesthesiol Scand (1994) 0.75
Candida albicans infection complicating percutaneous gastrostomy in cystic fibrosis. Br J Clin Pract (1995) 0.75
Ethambutol and the eye. Lancet (1988) 0.75
Unusual clinical signs complicating tension haemothorax. Br J Dis Chest (1984) 0.75
Respiratory progress chart. Physiotherapy (1980) 0.75
Triple therapy with isoniazid, rifampicin and pyrazinamide. Bull Int Union Tuberc Lung Dis (1988) 0.75
Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction. Br J Dis Chest (1980) 0.75
Proceedings: Inhaled corticosteroids compared with oral prednisone in asthmatic patients commencing regular corticosteroids. Tubercle (1975) 0.75
Acquired hemophilia and diabetes mellitus. Diabetes Care (1988) 0.75
Infrarenal aortic aneurysm surgery in a rural surgical service: risk factors for mortality. Aust N Z J Surg (1998) 0.75
Suppression of plasma neutrophil elastase-alpha1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia. J Allergy Clin Immunol (1997) 0.75
Smoking control and cessation. Br J Nurs (1993) 0.75
Psoas abscess following ingestion of psoas. Aust N Z J Surg (1992) 0.75
Management of asthma with beclomethasone dipropionate. A comparison of pressurized aerosol and rotahaler powder inhalation. Practitioner (1982) 0.75
Proceedings: Comparison of two bronchodilators--salmefamol and salbutamol. Tubercle (1975) 0.75
Oxygen as a driving gas for nebulizers: safe or dangerous. Br Med J (Clin Res Ed) (1984) 0.75
Mycobacterium avium disease: progress at last. Am J Respir Crit Care Med (1996) 0.75
Pulmonary veno-occlusive disease and Hodgkin's lymphoma. Eur Respir J (1993) 0.75
Pituitary hormones in diabetic ketoacidosis. Lancet (1978) 0.75